What should I expect if I enroll?
If you join the PRISM 3 trial, you will*:
- Meet with your study doctor to be randomly assigned to receive either a single dose of the study drug or placebo (no active ingredients) on Day 1 of the study
- Attend 7 clinic visits over a 6-month period
- Provide stool samples (using at-home collection kits) throughout the trial
- Be eligible to receive the study drug if you experience an episode of Clostridium difficile infection (CDI) within 8 weeks of of receiving the study drug or placebo, and choose to participate in a non-blinded extension trial. You would sign a separate informed consent form for this extension trial.
*See below for an overview of the patient visit schedule.
Trial staff experienced in clinical trials will monitor your health throughout the trial.
The costs for trial-related treatments, exams, and tests will be covered by the study sponsor, Finch Research and Development LLC.